Niagen Bioscience (NAGE) Total Debt (2016 - 2018)

Niagen Bioscience (NAGE) has 3 years of Total Debt data on file, last reported at $137000.0 in Q4 2018.

• On a quarterly basis, Total Debt fell 55.81% year-over-year to $137000.0 in Q4 2018; TTM through Dec 2018 was $137000.0, a 55.81% decrease from a year earlier, with the FY2018 full-year figure at $137000.0, down 55.81% from the prior year.
• Total Debt for Q4 2018 stood at $137000.0, down from $310000.0 in the prior quarter.
• Over the last five years, Total Debt for NAGE reached as high as $4.9 million in Q1 2016 and fell as low as $137000.0 in Q4 2018.
• Historically, Total Debt has averaged $1.4 million across 3 years, with a median of $327000.0 in 2016.
• Across the five-year window, Total Debt tumbled 92.94% in 2016 and fell 9.88% in 2017, its largest moves.
• Year by year, Total Debt stood at $344000.0 in 2016, then slipped by 9.88% to $310000.0 in 2017, then tumbled by 55.81% to $137000.0 in 2018.
• Per Business Quant data, the three most recent Total Debt figures were $137000.0 in Q4 2018, $310000.0 in Q4 2017, and $344000.0 in Q4 2016.